Marks Group Wealth Management Inc Has $3.02 Million Stock Holdings in Maximus, Inc. (NYSE:MMS)

Marks Group Wealth Management Inc reduced its position in shares of Maximus, Inc. (NYSE:MMS) by 58.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 36,030 shares of the health services provider’s stock after selling 51,296 shares during the period. Marks Group Wealth Management Inc’s holdings in Maximus were worth $3,021,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in MMS. New York State Common Retirement Fund grew its holdings in Maximus by 31.5% during the 4th quarter. New York State Common Retirement Fund now owns 31,898 shares of the health services provider’s stock worth $2,675,000 after acquiring an additional 7,641 shares during the last quarter. Verdence Capital Advisors LLC increased its holdings in Maximus by 3.2% in the fourth quarter. Verdence Capital Advisors LLC now owns 4,563 shares of the health services provider’s stock valued at $383,000 after purchasing an additional 140 shares during the period. Knights of Columbus Asset Advisors LLC raised its position in Maximus by 346.3% during the 4th quarter. Knights of Columbus Asset Advisors LLC now owns 118,290 shares of the health services provider’s stock worth $9,920,000 after purchasing an additional 91,788 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Maximus by 36.5% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,880 shares of the health services provider’s stock worth $1,080,000 after buying an additional 3,444 shares during the period. Finally, Louisiana State Employees Retirement System bought a new stake in shares of Maximus in the 4th quarter valued at about $1,434,000. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Stock Performance

Shares of MMS opened at $80.98 on Wednesday. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.71. The firm’s fifty day simple moving average is $82.64 and its two-hundred day simple moving average is $81.26. Maximus, Inc. has a 12 month low of $72.39 and a 12 month high of $89.69. The stock has a market capitalization of $4.94 billion, a P/E ratio of 26.81 and a beta of 0.72.

Maximus (NYSE:MMS) last announced its earnings results on Wednesday, February 7th. The health services provider reported $1.34 EPS for the quarter, beating the consensus estimate of $1.28 by $0.06. Maximus had a return on equity of 15.68% and a net margin of 3.73%. The company had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.29 billion. During the same quarter in the prior year, the company earned $0.94 EPS. The firm’s revenue for the quarter was up 6.2% compared to the same quarter last year. As a group, analysts predict that Maximus, Inc. will post 5.41 EPS for the current year.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 31st. Investors of record on Wednesday, May 15th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Tuesday, May 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.48%. Maximus’s payout ratio is presently 39.74%.

Insider Buying and Selling

In other news, CFO David Mutryn sold 8,000 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $83.95, for a total transaction of $671,600.00. Following the transaction, the chief financial officer now owns 5,124 shares in the company, valued at $430,159.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.40% of the stock is owned by insiders.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Raymond James downgraded Maximus from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 3rd. StockNews.com upgraded shares of Maximus from a “hold” rating to a “buy” rating in a report on Thursday, February 8th.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.